MedTrace Logo

Intravenous Lidocaine in the Prevention of Postoperative Vomiting in Elective Tonsil Surgery

NCT01986309 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2015-09-24

No results posted yet for this study

Summary

There some evidence regarding the effect of lidocaine for the prevention of nausea and vomiting in adults.

Conditions

  • Postoperative Nausea and Vomiting
  • Pain

Interventions

DRUG

Lidocaine

Bolus 1.5 mg/kg over 5 minutes, then an infusion of 2 mg/kg/h

DRUG

Normal saline

Sodium Chloride 0.9% infusion

Sponsors & Collaborators

  • Pontificia Universidad Catolica de Chile

    lead OTHER

Principal Investigators

  • Fernando R Altermatt, MD · Pontificia Universidad Catolica de Chile

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • Chile

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01986309 on ClinicalTrials.gov